The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University — Changsha, Hunan

Public research footprint of The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Advanced Cancer · Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Metastatic Breast Cancer · Advanced Solid Tumor

Recently updated registry entries

NCT07726342 — SMP-656 for HER2-Positive Advanced Breast Cancer (Not Yet Recruiting)
NCT06076291 — An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors (Active Not Recruiting)
NCT07061535 — Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.